Itacitinib Not Yet Recruiting Phase 2 Trials for Sclerosis, Progressive Systemic Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04789850Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis